The FDA is investigating these reports, though a causal relationship has not been definitively established
"Registered dietitians are exceptional sources of knowledge when it comes to supporting people on their GLP-1 journey to address any nutrition challenges and incorporate the food and benefits they need into their daily lives," Whitney Evans, PhD, RD and director, nutrition & scientific affairs, Danone North America, said in the release
Acknowledgements This work was partially supported by grants from JSPS (KAKENHI Grant Numbers JP21K08032 and 24K11270) to KS
A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
Addition of 10 mmol/l glutamine in the presence of 0 mmol/l glucose led to a 104% increase in apparent free cytosolic ATP (Fig
An Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk In a new analysis, KFF finds that 3.6 million people with Medicare could be eligible for coverage of Wegovy (semaglutide) now that the Food and Drug Administration has approved the use of the anti-obesity drug to reduce the risk of heart attacks and stroke in certain patients
